Article
The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
Arteriosclerosis, thrombosis, and vascular biology - 1 Feb 2000
Holvoet P, De Geest B, Van Linthout S, Lox M, Danloy S, Raes K, Collen D
Abstract excerpt
High density lipoprotein (HDL) metabolism and lecithin:cholesterol acyltransferase (LCAT)-induced HDL remodeling were investigated in transgenic mice expressing human apolipoprotein (apo) AI or an apoAI/apoAII chimera in which the Arg123-Tyr166 domain of apoAI was substituted with the Ser12-Ala75 domain of apoAII. Expression of apoAI and of the apoAI/apoAII chimera resulted in a respective 3. 5-fold and 2.9-fold...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.